세계의 주사기 시장 규모, 점유율, 동향 분석 보고서 : 사용 방법별, 디자인별, 용도별, 소재별, 최종 용도별, 지역별, 부문별 예측(2025-2033년)

Syringes Market Summary

The global syringes market size was estimated at USD 17.03 billion in 2024 and is projected to reach USD 35.61 billion by 2033, growing at a CAGR of 8.66% from 2025 to 2033. The demand for syringes is rising owing to the increasing burden of chronic disorders, the rising number of surgical procedures, and the growing hospitalizations.

In addition, the advancements in syringes are anticipated to propel the market growth. The increasing prevalence of chronic diseases and the resulting hospitalizations are major market drivers. According to the data published by the WHO in December 2024, chronic diseases claimed the lives of at least 43 million people globally in 2021. In addition, a study published by the Mayo Clinic in February 2024 projects that the global economic burden of chronic diseases will reach an estimated USD 47 trillion by 2030. This growing burden underscores the rising demand for medical supplies, including syringes, as healthcare systems work to manage and treat these long-term conditions.

Furthermore, the rising number of hospitalizations and an increasing volume of surgical procedures drive the demand for syringes in the coming years. As surgical interventions, including cosmetic, cardiac, and orthopedic surgeries, become more prevalent across various countries and regions, the need for syringes grows. These surgeries often require the use of syringes for anesthesia and medication delivery, contributing to the overall surge in demand. Moreover, advancements in surgical techniques and a growing patient population further support this rising need for syringes in healthcare settings.

The growing emphasis on safety and auto-disable syringes is expected to propel market growth in the coming years. Companies are increasingly innovating their product offerings with these advanced solutions. For example, in March 2024, Hindusta Syringes and Medical Devices introduced the Dispojekt single-use syringes with safety needles. These syringes aim to reduce the risk of accidental needle-stick injuries (NSIs) among healthcare workers, lower infection control costs, and minimize expenses related to disposal and training, ultimately delivering long-term financial benefits to the healthcare sector.

Moreover, the growing demand for vaccinations and immunizations is driving the need for syringes, with new market entrants focusing on manufacturing auto-disable syringes to meet this demand. For example, according to data published by VaccinesWork in February 2024, Revital Healthcare has become the first African manufacturer of WHO-prequalified, single-use, safe syringes. These African-made auto-disable (AD) syringes enhance immunization efforts across the continent. In Kenya, the immunization system strongly advocates for AD syringes, which are developed to prevent reuse by locking automatically post single injection, making them the gold standard for vaccination safety.

"Average syringe transport times are expected to decrease by up to 80-90% on the continent". Said Roneek R. Vora, director, Revital Healthcare (EPZ) Limited

"We broke barriers by exporting these syringes to more than 35 countries, including India - despite India being a syringe production powerhouse -and four European countries, and to other African countries." Says Vora, who is also a founding member of the Kenyan Ministry of Health's End Malaria Council & Fund.

Such increasing manufacturing and export of auto-disabled syringes for vaccinations and immunizations is anticipated to propel market growth in the coming years.

To learn more about this report, request a free sample copy

In addition, the availability of syringes in various sizes supports market growth. The pictorial representation below highlights the prices of some auto-disabled syringes along with their size and brand name for 2022 and 2023.

Global Syringes Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global syringes market report based on design, usage, application, material, end use, and region:

• Usage Outlook (Revenue, USD Million, 2021 - 2033)
• Disposable Syringes
• Reusable Syringes
• Design Outlook (Revenue, USD Million, 2021 - 2033)
• Conventional Syringes
• Safety Syringes
  • Retractable Safety Syringes
  • Non-Retractable Safety Syringes
• Prefilled Syringes (PFS)
• Smart Syringes
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Vaccines and Immunizations
• Anaphylaxis
• Rheumatoid Arthritis
• Diabetes
• Autoimmune Diseases
• Oncology
• Others
• Material Outlook (Revenue, USD Million, 2021 - 2033)
• Plastic Syringes
• Glass Syringes
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Direct Tenders
• Hospital Pharmacies
• Retail Pharmacies
• Online Pharmacies
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • South Korea
  • Australia
  • Thailand
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation & Scope
  • 1.1.1. Design
  • 1.1.2. Usage
  • 1.1.3. Application
  • 1.1.4. Material
  • 1.1.5. End-use
  • 1.1.6. Regional scope
  • 1.1.7. Estimates and forecast timeline
• 1.2. Research Methodology
• 1.3. Information Procurement
  • 1.3.1. Purchased database
  • 1.3.2. GVR's internal database
  • 1.3.3. Secondary sources
  • 1.3.4. Primary research
  • 1.3.5. Details of primary research
• 1.4. Information or Data Analysis
  • 1.4.1. Data analysis models
• 1.5. Market Formulation & Validation
• 1.6. Model Details
  • 1.6.1. Commodity flow analysis (Model 1)
    • 1.6.1.1. Approach 1: Commodity flow approach
  • 1.6.2. Volume price analysis (Model 2)
    • 1.6.2.1. Approach 2: Volume price analysis
• 1.7. List of Secondary Sources
• 1.8. List of Primary Sources
• 1.9. Objectives
  • 1.9.1. Objective 1
  • 1.9.2. Objective 2

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Syringes Market Variables, Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent market outlook
• 3.2. Market Dynamics
  • 3.2.1. Market driver analysis
    • 3.2.1.1. Increasing demand for vaccination and immunization
    • 3.2.1.2. Rising adoption of safety and prefilled syringes
    • 3.2.1.3. Increasing disease burden
    • 3.2.1.4. Technological advancements
    • 3.2.1.5. Rising production capacities for syringes
  • 3.2.2. Market restraint analysis
    • 3.2.2.1. Recalls of syringes
  • 3.2.3. Market opportunity analysis
    • 3.2.3.1. Growing number of clinical trials
    • 3.2.3.2. Increasing development of auto-disable syringes
    • 3.2.3.3. Growth potential in emerging economies in syringes market
    • 3.2.3.4. Rising distribution partnerships
  • 3.2.4. Market challenge analysis
    • 3.2.4.1. Potential complications and risks associated with syringes
• 3.3. Syringes Market Analysis Tools
  • 3.3.1. Industry Analysis - Porter's
    • 3.3.1.1. Bargaining power of suppliers
    • 3.3.1.2. Bargaining power of buyers
    • 3.3.1.3. Threat of substitutes
    • 3.3.1.4. Threat of new entrants
    • 3.3.1.5. Competitive rivalry
  • 3.3.2. PESTEL Analysis
    • 3.3.2.1. Political & Legal Landscape
    • 3.3.2.2. Economic and Social Landscape
    • 3.3.2.3. Technological landscape

Chapter 4. Syringes Market: Usage Estimates & Trend Analysis

• 4.1. Segment Dashboard
• 4.2. Global Syringes Market Usage Movement Analysis
• 4.3. Global Syringes Market Size & Trend Analysis, by Usage, 2021 to 2033 (USD Million)
• 4.4. Disposable Syringes
  • 4.4.1. Disposable syringes market estimates and forecasts, 2021 - 2033 (USD Million)
• 4.5. Reusable Syringes
  • 4.5.1. Reusable syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 5. Syringes Market: Design Estimates & Trend Analysis

• 5.1. Segment Dashboard
• 5.2. Global Syringes Market Design Movement Analysis
• 5.3. Global Syringes Market Size & Trend Analysis, by Design, 2021 to 2033 (USD Million)
• 5.4. Conventional Syringes
  • 5.4.1. Conventional syringes market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.5. Safety Syringes
  • 5.5.1. Safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.1.1. Retractable Safety Syringes
      • 5.5.1.1.1. Retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
    • 5.5.1.2. Non-retractable Safety Syringes
      • 5.5.1.2.1. Non-retractable safety syringes market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.6. Prefilled Syringes (PFS)
  • 5.6.1. Prefilled syringes (PFS) market estimates and forecasts, 2021 - 2033 (USD Million)
• 5.7. Smart Syringes
  • 5.7.1. Smart syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 6. Syringes Market: Application Estimates & Trend Analysis

• 6.1. Segment Dashboard
• 6.2. Global Syringes Market Application Movement Analysis
• 6.3. Global Syringes Market Size & Trend Analysis, by Application, 2021 to 2033 (USD Million)
• 6.4. Vaccines and Immunizations
  • 6.4.1. Vaccines and immunizations market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.5. Anaphylaxis
  • 6.5.1. Anaphylaxis market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.6. Rheumatoid Arthritis
  • 6.6.1. Rheumatoid arthritis market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.7. Diabetes
  • 6.7.1. Diabetes market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.8. Autoimmune Diseases
  • 6.8.1. Autoimmune diseases market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.9. Oncology
  • 6.9.1. Oncology market estimates and forecasts, 2021 - 2033 (USD Million)
• 6.10. Others
  • 6.10.1. Others market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 7. Syringes Market: Material Estimates & Trend Analysis

• 7.1. Segment Dashboard
• 7.2. Global Syringes Market Material Movement Analysis
• 7.3. Global Syringes Market Size & Trend Analysis, by Material, 2021 to 2033 (USD Million)
• 7.4. Plastic Syringes
  • 7.4.1. Plastic syringes market estimates and forecasts, 2021 - 2033 (USD Million)
• 7.5. Glass Syringes
  • 7.5.1. Glass syringes market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 8. Syringes Market: End Use Estimates & Trend Analysis

• 8.1. Segment Dashboard
• 8.2. Global Syringes Market End Use Movement Analysis
• 8.3. Global Syringes Market Size & Trend Analysis, by End Use, 2021 to 2033 (USD Million)
• 8.4. Direct Tenders
  • 8.4.1. Direct tenders market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.5. Hospital Pharmacies
  • 8.5.1. Hospital pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.6. Retail Pharmacies
  • 8.6.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)
• 8.7. Online Pharmacies
  • 8.7.1. Retail pharmacies market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 9. Syringes Market: Regional Estimates & Trend Analysis By Design, By Usage, By Application, By Material, By End Use

• 9.1. Regional Dashboard
• 9.2. Market Size & Forecasts and Trend Analysis, 2021 to 2033
• 9.3. North America
  • 9.3.1. Market estimates and forecast, 2021 - 2033 (USD Million)
  • 9.3.2. U.S.
    • 9.3.2.1. Key country dynamics
    • 9.3.2.2. Competitive scenario
    • 9.3.2.3. Regulatory framework
    • 9.3.2.4. Reimbursement scenario
    • 9.3.2.5. U.S. market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.3. Canada
    • 9.3.3.1. Key country dynamics
    • 9.3.3.2. Competitive scenario
    • 9.3.3.3. Regulatory framework
    • 9.3.3.4. Reimbursement scenario
    • 9.3.3.5. Canada market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.3.4. Mexico
    • 9.3.4.1. Key country dynamics
    • 9.3.4.2. Competitive scenario
    • 9.3.4.3. Regulatory framework
    • 9.3.4.4. Reimbursement scenario
    • 9.3.4.5. Mexico market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.4. Europe
  • 9.4.1. UK
    • 9.4.1.1. Key country dynamics
    • 9.4.1.2. Competitive scenario
    • 9.4.1.3. Regulatory framework
    • 9.4.1.4. Reimbursement scenario
    • 9.4.1.5. UK market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.2. Germany
    • 9.4.2.1. Key country dynamics
    • 9.4.2.2. Competitive scenario
    • 9.4.2.3. Regulatory framework
    • 9.4.2.4. Reimbursement scenario
    • 9.4.2.5. Germany market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.3. France
    • 9.4.3.1. Key country dynamics
    • 9.4.3.2. Competitive scenario
    • 9.4.3.3. Regulatory framework
    • 9.4.3.4. Reimbursement scenario
    • 9.4.3.5. France market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.4. Italy
    • 9.4.4.1. Key country dynamics
    • 9.4.4.2. Competitive scenario
    • 9.4.4.3. Regulatory framework
    • 9.4.4.4. Reimbursement scenario
    • 9.4.4.5. Italy market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.5. Spain
    • 9.4.5.1. Key country dynamics
    • 9.4.5.2. Competitive scenario
    • 9.4.5.3. Regulatory framework
    • 9.4.5.4. Reimbursement scenario
    • 9.4.5.5. Spain market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.6. Denmark
    • 9.4.6.1. Key country dynamics
    • 9.4.6.2. Competitive scenario
    • 9.4.6.3. Regulatory framework
    • 9.4.6.4. Reimbursement scenario
    • 9.4.6.5. Denmark market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.7. Sweden
    • 9.4.7.1. Key country dynamics
    • 9.4.7.2. Competitive scenario
    • 9.4.7.3. Regulatory framework
    • 9.4.7.4. Reimbursement scenario
    • 9.4.7.5. Sweden market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.4.8. Norway
    • 9.4.8.1. Key country dynamics
    • 9.4.8.2. Competitive scenario
    • 9.4.8.3. Regulatory framework
    • 9.4.8.4. Reimbursement scenario
    • 9.4.8.5. Norway market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.5. Asia Pacific
  • 9.5.1. Japan
    • 9.5.1.1. Key country dynamics
    • 9.5.1.2. Competitive scenario
    • 9.5.1.3. Regulatory framework
    • 9.5.1.4. Reimbursement scenario
    • 9.5.1.5. Japan market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.2. India
    • 9.5.2.1. Key country dynamics
    • 9.5.2.2. Competitive scenario
    • 9.5.2.3. Regulatory framework
    • 9.5.2.4. Reimbursement scenario
    • 9.5.2.5. India market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.3. China
    • 9.5.3.1. Key country dynamics
    • 9.5.3.2. Competitive scenario
    • 9.5.3.3. Regulatory framework
    • 9.5.3.4. Reimbursement scenario
    • 9.5.3.5. China market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.4. South Korea
    • 9.5.4.1. Key country dynamics
    • 9.5.4.2. Competitive scenario
    • 9.5.4.3. Regulatory framework
    • 9.5.4.4. Reimbursement scenario
    • 9.5.4.5. South Korea market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.5. Australia
    • 9.5.5.1. Key country dynamics
    • 9.5.5.2. Competitive scenario
    • 9.5.5.3. Regulatory framework
    • 9.5.5.4. Reimbursement scenario
    • 9.5.5.5. Australia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.5.6. Thailand
    • 9.5.6.1. Key country dynamics
    • 9.5.6.2. Competitive scenario
    • 9.5.6.3. Regulatory framework
    • 9.5.6.4. Reimbursement scenario
    • 9.5.6.5. Thailand market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.6. Latin America
  • 9.6.1. Brazil
    • 9.6.1.1. Key country dynamics
    • 9.6.1.2. Competitive scenario
    • 9.6.1.3. Regulatory framework
    • 9.6.1.4. Reimbursement scenario
    • 9.6.1.5. Brazil market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.6.2. Argentina
    • 9.6.2.1. Key country dynamics
    • 9.6.2.2. Competitive scenario
    • 9.6.2.3. Regulatory framework
    • 9.6.2.4. Reimbursement scenario
    • 9.6.2.5. Argentina market estimates and forecasts, 2021 - 2033 (USD Million)
• 9.7. MEA
  • 9.7.1. South Africa
    • 9.7.1.1. Key country dynamics
    • 9.7.1.2. Competitive scenario
    • 9.7.1.3. Regulatory framework
    • 9.7.1.4. Reimbursement scenario
    • 9.7.1.5. South Africa market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.2. Saudi Arabia
    • 9.7.2.1. Key country dynamics
    • 9.7.2.2. Competitive scenario
    • 9.7.2.3. Regulatory framework
    • 9.7.2.4. Reimbursement scenario
    • 9.7.2.5. Saudi Arabia market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.3. UAE
    • 9.7.3.1. Key country dynamics
    • 9.7.3.2. Competitive scenario
    • 9.7.3.3. Regulatory framework
    • 9.7.3.4. Reimbursement scenario
    • 9.7.3.5. UAE market estimates and forecasts, 2021 - 2033 (USD Million)
  • 9.7.4. Kuwait
    • 9.7.4.1. Key country dynamics
    • 9.7.4.2. Competitive scenario
    • 9.7.4.3. Regulatory framework
    • 9.7.4.4. Reimbursement scenario
    • 9.7.4.5. Kuwait market estimates and forecasts, 2021 - 2033 (USD Million)

Chapter 10. Competitive Landscape

• 10.1. Recent Developments & Impact Analysis, By Key Market Participants
• 10.2. Company/Competition Categorization
  • 10.2.1. Innovators
• 10.3. Vendor Landscape
  • 10.3.1. List of key distributors and channel partners
  • 10.3.2. Key customers
  • 10.3.3. Global Key company market share analysis, 2024
  • 10.3.4. Revital
    • 10.3.4.1. Company overview
    • 10.3.4.2. Financial performance
    • 10.3.4.3. Design benchmarking
    • 10.3.4.4. Strategic initiatives
  • 10.3.5. Hindustan Syringes & Medical Devices Ltd
    • 10.3.5.1. Company overview
    • 10.3.5.2. Financial performance
    • 10.3.5.3. Design benchmarking
    • 10.3.5.4. Strategic initiatives
  • 10.3.6. Wuxi Yushou Medical Appliances Co., Ltd
    • 10.3.6.1. Company overview
    • 10.3.6.2. Financial performance
    • 10.3.6.3. Design benchmarking
    • 10.3.6.4. Strategic initiatives
  • 10.3.7. Nipro Europe Group Companies
    • 10.3.7.1. Company overview
    • 10.3.7.2. Financial performance
    • 10.3.7.3. Design benchmarking
    • 10.3.7.4. Strategic initiatives
  • 10.3.8. Abu Dhabi Medical Devices Company
    • 10.3.8.1. Company overview
    • 10.3.8.2. Financial performance
    • 10.3.8.3. Design benchmarking
    • 10.3.8.4. Strategic initiatives
  • 10.3.9. B. Braun SE
    • 10.3.9.1. Company overview
    • 10.3.9.2. Financial performance
    • 10.3.9.3. Design benchmarking
    • 10.3.9.4. Strategic initiatives
  • 10.3.10. BD
    • 10.3.10.1. Company overview
    • 10.3.10.2. Financial performance
    • 10.3.10.3. Design benchmarking
    • 10.3.10.4. Strategic initiatives
  • 10.3.11. Sharps Technology, Inc.
    • 10.3.11.1. Company overview
    • 10.3.11.2. Financial performance
    • 10.3.11.3. Design benchmarking
    • 10.3.11.4. Strategic initiatives
  • 10.3.12. Cardinal Health
    • 10.3.12.1. Company overview
    • 10.3.12.2. Financial performance
    • 10.3.12.3. Design benchmarking
    • 10.3.12.4. Strategic initiatives
  • 10.3.13. Vita Needle Company
    • 10.3.13.1. Company overview
    • 10.3.13.2. Financial performance
    • 10.3.13.3. Design benchmarking
    • 10.3.13.4. Strategic initiatives
  • 10.3.14. Terumo Europe NV
    • 10.3.14.1. Company overview
    • 10.3.14.2. Financial performance
    • 10.3.14.3. Design benchmarking
    • 10.3.14.4. Strategic initiatives
  • 10.3.15. Taisei Kako Ltd
    • 10.3.15.1. Company overview
    • 10.3.15.2. Financial performance
    • 10.3.15.3. Design benchmarking
    • 10.3.15.4. Strategic initiatives
  • 10.3.16. ulti med Products
    • 10.3.16.1. Company overview
    • 10.3.16.2. Financial performance
    • 10.3.16.3. Design benchmarking
    • 10.3.16.4. Strategic initiatives
  • 10.3.17. Henke Sass Wolf GmbH
    • 10.3.17.1. Company overview
    • 10.3.17.2. Financial performance
    • 10.3.17.3. Design benchmarking
    • 10.3.17.4. Strategic initiatives
  • 10.3.18. ITO CORPORATION
    • 10.3.18.1. Company overview
    • 10.3.18.2. Financial performance
    • 10.3.18.3. Design benchmarking
    • 10.3.18.4. Strategic initiatives
  • 10.3.19. Retractable Technologies, Inc.
    • 10.3.19.1. Company overview
    • 10.3.19.2. Financial performance
    • 10.3.19.3. Design benchmarking
    • 10.3.19.4. Strategic initiatives
  • 10.3.20. kohope.com
    • 10.3.20.1. Company overview
    • 10.3.20.2. Financial performance
    • 10.3.20.3. Design benchmarking
    • 10.3.20.4. Strategic initiatives
  • 10.3.21. Al Shifa Medical Products Co
    • 10.3.21.1. Company overview
    • 10.3.21.2. Financial performance
    • 10.3.21.3. Design benchmarking
    • 10.3.21.4. Strategic initiatives
  • 10.3.22. Liaoning Kangyi Medical Equipment Co., Ltd
    • 10.3.22.1. Company overview
    • 10.3.22.2. Financial performance
    • 10.3.22.3. Design benchmarking
    • 10.3.22.4. Strategic initiatives
  • 10.3.23. CANE SPA
    • 10.3.23.1. Company overview
    • 10.3.23.2. Financial performance
    • 10.3.23.3. Design benchmarking
    • 10.3.23.4. Strategic initiatives
  • 10.3.24. SMB Corporation of India
    • 10.3.24.1. Company overview
    • 10.3.24.2. Financial performance
    • 10.3.24.3. Design benchmarking
    • 10.3.24.4. Strategic initiatives
  • 10.3.25. Lifelong Meditech Private Limited.
    • 10.3.25.1. Company overview
    • 10.3.25.2. Financial performance
    • 10.3.25.3. Design benchmarking
    • 10.3.25.4. Strategic initiatives
  • 10.3.26. OSAKA CHEMICAL Co., Ltd
    • 10.3.26.1. Company overview
    • 10.3.26.2. Financial performance
    • 10.3.26.3. Design benchmarking
    • 10.3.26.4. Strategic initiatives
  • 10.3.27. JMS Co.Ltd
    • 10.3.27.1. Company overview
    • 10.3.27.2. Financial performance
    • 10.3.27.3. Design benchmarking
    • 10.3.27.4. Strategic initiatives
  • 10.3.28. APEX MEDICAL DEVICES
    • 10.3.28.1. Company overview
    • 10.3.28.2. Financial performance
    • 10.3.28.3. Design benchmarking
    • 10.3.28.4. Strategic initiatives
  • 10.3.29. Cartel Health Care Pvt. Ltd
    • 10.3.29.1. Company overview
    • 10.3.29.2. Financial performance
    • 10.3.29.3. Design benchmarking
    • 10.3.29.4. Strategic initiatives
  • 10.3.30. VEM Tooling Co., Ltd. (VEM Thailand Co., Ltd.)
    • 10.3.30.1. Company overview
    • 10.3.30.2. Financial performance
    • 10.3.30.3. Design benchmarking
    • 10.3.30.4. Strategic initiatives
  • 10.3.31. Fresenius Kabi Canada Ltd
    • 10.3.31.1. Company overview
    • 10.3.31.2. Financial performance
    • 10.3.31.3. Design benchmarking
    • 10.3.31.4. Strategic initiatives
  • 10.3.32. ICU Medical, Inc.
    • 10.3.32.1. Company overview
    • 10.3.32.2. Financial performance
    • 10.3.32.3. Design benchmarking
    • 10.3.32.4. Strategic initiatives
• 10.4. Heat Map Analysis/ Company Market Position Analysis
• 10.5. Estimated Company Market Share Analysis, 2024
• 10.6. List of Other Key Market Players